Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

BACKGROUND: The dynamic change in C-reactive protein (CRP) levels, CRP kinetics, is a prognostic factor for metastatic renal cell carcinoma (mRCC) in the tyrosine kinase inhibitor era. We investigated the impact of early CRP kinetics on the efficacy of nivolumab in patients with mRCC. METHODS: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Shohei, Saito, Kazutaka, Yasuda, Yosuke, Kijima, Toshiki, Yoshida, Soichiro, Yokoyama, Minato, Ishioka, Junichiro, Matsuoka, Yoh, Kageyama, Yukio, Fujii, Yasuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896625/
https://www.ncbi.nlm.nih.gov/pubmed/33602695
http://dx.doi.org/10.1136/jitc-2020-001564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896625/
https://www.ncbi.nlm.nih.gov/pubmed/33602695
http://dx.doi.org/10.1136/jitc-2020-001564

Ejemplares similares